Canada· CA-DIN-02142783
ROBITUSSIN EXTRA STRENGTH MUCUS AND PHLEGM
A guaifenesin product containing guaifenesin, registered in Canada by HALEON CANADA ULC. The same ATC class is registered in 14 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Guaifenesin is registered in 14 of 19 countries.
Countries holding a registration under ATC R05CA03 (guaifenesin), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 9 of them publish a price we can compare per daily dose
Guaifenesin · ATC R05CA03
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of guaifenesin costs, country by country.
Normalised to the WHO defined daily dose (0.9 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Guaifenesin · price per daily dose (0.9 g)
USD · FX 28 Sept 2026
- US United States$0.29 (acquisition cost)
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- GUAIFENESIN
- Manufacturer
- HALEON CANADA ULC
- Country
- Canada (CA)
- ATC code
- R05CA03
- ATC class
- Guaifenesin
- Defined daily dose
- 0.9 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Guaifenesin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBronchosedal Mucus Honing & Citroen Unidose 200 mgKenvue Belgium
- SwedenNipenesin 200 mg Sirap i dospåseMcNeil Sweden AB
- United States12 Hour Mucus ReliefCHAIN DRUG MARKETING ASSOCIATION INC
- United KingdomAdult Meltus for Chesty Coughs and Catarrh oral solutionSSL International Plc
- CzechiaGUAJACURANZentiva, k.s., Praha
- IrelandBenylin Children’s Chesty Cough 50 mg/5 ml SyrupJNTL Consumer Health (Ireland) Limited
- FinlandResyl SNovartis Finland Oy
- SpainFORMULAEXPEC 13,33 mg/ml JARABE SABOR MIELLaboratorios Vicks S.L.
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Bronchostop Akut, Grippostad Guaifenesin
- Belgium · Bronchosedal Mucus Honig & Zitrone, Bronchosedal Mucus Honing & Citroen
- Cyprus · Benylin Mucus Cough Warm Honey & Lemon Flavour
- Czechia · Guajacuran, Medexpecto Vicks Sirup Med A Zázvor
- Germany · Fagusan, Wick Husten-Löser Mit Honigaroma
- Denmark · Benysine
- Estonia · Expexin
- Spain · Formulaexpec, Frispec
- France · Vicks Expectorant Adultes Miel
- United Kingdom (Northern Ireland) · Bell’s Healthcare Mucus Cough, Benylin Children's Chesty Coughs
- Greece · Hexacough Warm Honey & Lemon
- Hungary · Relaxil-G, Robitussin Expectorans
- Ireland · Benylin Children's Chesty Cough, Benylin Mucus Cough Honey & Lemon
- Iceland · Túfen
- Italy · Actigrip Tosse Mucolitico "gusto Mentolo”, Vicks Tosse Fluidificante
- Lithuania · Expexin
- Luxembourg · Bronchosedal Mucus Menthol, Bronchosedal Mucus Miel & Citron
- Latvia · Expexin
- Norway · Benysine Med Honning- Og Sitronsmak, Solvipect
- Poland · Guajazyl, Robitussin Expectorans
- Portugal · Vicks Expectorante Mel
- Romania · Robitussin Expectorans, Vicks Expectorant
- Sweden · Nipenesin, Nipenesin Mentol
- Slovakia · Guajacuran, Robitussin Expectorans Na Vykašliavanie
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb3bdcc8-e1d7-469a-8c6e-f0c27c3be036 GET /v1/drugs/cb3bdcc8-e1d7-469a-8c6e-f0c27c3be036?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02142783",
"form": "SYRUP",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "R05CA03",
"schedule": [
"OTC"
],
"drug_code": "19044",
"strengths": [
"200 MG"
],
"ahfs_class": null,
"substances": [
"GUAIFENESIN"
],
"product_categorization": "LS - EXPECTORANT - ADULT"
}See everything about guaifenesin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.